All higher organisms produce cationic antimicrobial peptides (AMPs) 1 whose main targets of action are membranes and associated biological functions 2 . Bacteria cannot easily reorganize, nor can they markedly alter, their lipid composition or their requirement for a strong, inside-directed electric field (attracting cations). For these reasons, AMPs have a low tendency to elicit resistance and show a moderate selectivity for bacterial cells.
A large group of AMPs acquire an amphipathic α-helical secondary structure in a low dielectric constant environment, such as when they interact with the cytoplasmic membrane 3 , but in most cases their primary structure has not been related with quantitative parameters expressing their activity against either bacterial or host cells. Even when structural parameters affecting activity are known, it is a challenge to maintain or increase antibacterial activity while simultaneously decreasing hemolytic activity, since some optimal combination of specific attributes must be reached 4 . Increasing peptide selectivity requires a better definition of those structural features of AMPs which have evolved to ensure a selective action in fending off microbes without endangering host cells.
We have created an AMP activity database (AMPad) of 73 frog-derived AMPs with propensity to form amphipathic helices in membrane-mimetic solvents, which connects measured peptide selectivity with associated primary structures (Supplementary Tables S1   and S2 ). Published results were selected only where antimicrobial activity was determined by the serial dilution method, in terms of the minimal inhibitory concentration (MIC) towards E.
coli, and cytotoxicity expressed in terms of 50% hemolysis of fresh human blood cells (HC 50 ).
The therapeutic index (TI), a measure of peptide selectivity, is then defined as: TI = HC 50 /MIC. To extract rules as general as possible we have then divided the AMPad database in a training data set of 36 non-homologous (less than 70% pair-wise identity) peptides and a test data set of the 37 remaining peptides. All but two peptides (pexiganan and gaegurin 4 W16) in the training set were of natural origin.
Our first goal was to find a one-parameter linear model for correlating measured and predicted TI values. To the best of our knowledge, non-homologous antimicrobial peptides have never been used before in quantitative structure-activity studies of TI. Furthermore, most structure-activity studies of AMPs used multi-linear models for predicting peptide activity 5 .
Models with only one peptide descriptor were not expected to work, due to the well know necessity to use several interrelated structural and physicochemical parameters that all modulate activity and specificity, such as charge, secondary structure, amphipathicity, and
A different approach is however possible, which does not use peptide mean properties as given descriptors, but instead exploits the observation 4, 6 that position-dependent physicochemical properties also determine peptide activity and selectivity. Position-dependent amino acid attributes are usually represented as smoothed, two-dimensional sequence profiles, such as the Kyte-Doolittle hydrophobicity profile. To simplify analyses, the whole sequence profile for chosen amino acid attributes can be converted into one vector with two components (x and y). This can be easily done by bending the sequence in, for instance, a right angle arc, and then performing vector summation of attribute vectors associated with all amino acids in the sequence (Figure 1) . A vector sum that replaces the sequence profile will be named the sequence moment. Unlike a peptide's amphipathicity, which is quantified by Eisenberg's hydrophobic moment 7 , the sequence moment does not depend on knowledge of the secondary structure, but rather is an indicator of peptide lengthwise asymmetry.
Amino acid attribute profiles were obtained by selecting 144 amino acid scales used to study integral membrane proteins and protein folding [8] [9] [10] . The simplest methods for finding sequence profiles were then: a) direct usage of amino acid attributes, or b) smoothed amino acid attributes associated with a central amino acid in a sliding window either considering all residues in the window (mean values) or without taking into account the attribute of the central amino acid itself (sequence environment values). Using any one of the selected 144 scales to derive scalars from the corresponding sequence moments, we could not however achieve the desired high correlation among these descriptors and measured TI. The next simplest choice was to use sequence moments for two different amino acid scales and to examine for which pair any given scalar descriptor, derived from the two sequence moments, will give the desired high correlation.
The simplest parameter thus obtained, providing a correlation Figure S2) . Figure 1 illustrates that angular separation of sequence moments is quite different for a highly selective (PGLa)(Supplementary Method 1) and a mediocre peptide antibiotic (pseudin 2). Notice that peptide lengthwise asymmetry is additionally strengthened by modeling the observation that amino acids closer to N-terminus are more relevant for peptide activity 3, 13 .
The D descriptor then helped us in our second goal; to create an algorithm capable of proposing novel peptides with a potentially high therapeutic index. The number of possible peptides, even when we restrict ourselves to a 23 amino acid length, is however extremely large. We used a recursive algorithm and imposed various rational restrictions to reduce these to a workable number of potential AMP candidates with a high TI (see Methods,
Supplementary Method 2 and Supplementary Tables S3-S5).
General requirements included i) mean hydrophobicity values according to the CCS scale within an allowed range, 3, 14 ii) predicted TI values of at least 85, and iii) limiting design to amphipathic helix-forming peptides. A statistical analysis of the most common motifs and amino acids associated with the set of best peptides led to the remaining set of restrictions out of which the motif regularity index is probably the most important innovation.
As a result, the AMP-Designer algorithm produced the 7 peptides (out of 29 8 10 ≈ ⋅ possibilities, see Methods). Six of these end with a cysteine residue, which may be a vestige from the so called "Rana-box", a cysteine-bridged stretch present at the C-terminus of many frog-derived helical antimicrobial peptides 3, 15 , which is not correlated with increased activity or selectivity 15 . Hence, we considered the best candidate for synthesis and characterization to be the seventh: GIGKHVGKALKGLKGLLKGLGES (DESC 1), with a predicted TI = 86, mean hydrophobicity 14 H = -1.0, and a relative amphipathicity 16 helix-helix interaction in the membrane 17 . Neglecting the requirement that the predicted TI be higher than 85 (ie. D descriptor omission), would have lead to a total of 37 designed peptides, indicating that using the D descriptor was useful in eliminating 81% of these peptides.
The suggested peptide was synthesized in good purity (Supplementary Figure S3) , together with two known frog peptides from the training database. Ascaphin 1 and pseudin 2
were selected as controls because we hoped that observed structural and functional properties of DESC1 would span the range of corresponding peptide attributes for good and mediocre peptide antibiotics. This was indeed the case for most attributes (see Supplementary Figure   S4 and Supplementary Table S6 ). For instance, despite the presence of numerous glycine residues, DESC1 has an estimated helical content of about 70% in the presence of the helix promoting solvent TFE.
Antimicrobial activity assays confirmed that the DESC 1 is selectively active against
Gram-negative bacteria ( Table 1) . Its C-terminally amidated form had a MIC value of 2-4 μM against E. coli, against which it was designed, and a moderate activity also towards P.
aeruginosa, whereas its activity is poor against the Gram-positive bacterium S. aureus. The designed peptide did not quite reach 50% lysis of red blood cells even at the highest concentration tested; 800 μM ( Table 1 and Figure 2 ). By comparison, pseudin showed a HC 50 of 50 μM under the same conditions, and ascaphin of 80 μM. Using these data to determine experimental TI values, and comparing them with predicted TI, we found values for control peptides of 6 against the predicted 8 for pseudin, 39 against the predicted 55 for ascaphin ( Table 1 and Supplementary Table S1 ). These data, together with those for DESC 1, with a measured TI value of over 200 against the predicted 86, more than confirm the design method.
The high selectivity of the designed peptide DESC1 may in part derive from its unusual primary structure, which contains seven glycine residues, and which is ≤ 50% identical to any known helical AMP, being closest to bombinin (BMN_BOMVA, accession P01505, 50% identity). Based on a statistical analysis of natural helical AMPs 3 , glycine residues have an increased frequency at position 7 or 14. It was shown that placing a Gly residue at position 7 in a 19mer artificial helical AMP 18 , somewhat increased selectivity, while placing Gly in position 14, or 7 and 14 considerably reduced antimicrobial potency, so there seemed to be positional requirements for its use in increasing selectivity. Using the D descriptor in connection with the AMP-Designer algorithm it was possible to simultaneously introduce 6 internal glycine residues without markedly reducing activity towards Gramnegative microorganisms, while dramatically increasing selectivity.
The flexibility of the DESC1 peptide and its Gly distribution pattern may have the dual role of facilitating unstructured monomers to pass easily through cell wall components 19 and of increasing the probability of transient monomer aggregation and pore formation at the level of the cytoplasmic membrane. Being different from any known AMP, the DESC1 peptide can be considered as the first member of new glycine-rich class of helical AMP lead compounds for potential medical applications.
Our method offers rational peptide design for maximizing target selectivity (against The concept and the algorithm used to design DESC1 are also likely to be useful tools for redesign and selectivity optimization of existing helix-type AMPs. The separation of sequence moments is such a sensitive descriptor that it can predict large TI increase even after a single point mutation. One example is the correct prediction of the TI value increase from a measured value of 20 (predicted value of 19.6) for magainin 2, to a measured value of 125
(predicted value of 94) for magainin 2 F5W 6 (Supplementary Figure S5) . This confirms the potential usefulness of the D descriptor, when associated with appropriate constraints, for developing and refining new lead compounds with increased selectivity against Gramnegative bacteria.
Methods

Statistical methods
We used the correlation between a given descriptor, derived from sequence moments, and the measured TI values in the training data set of 36 non-homologous peptides as selection criterion. To calculate sequence moments (see Figure 1 legend 
Note that some of these numbers correspond to one scale only, but with such a choice of scalar descriptors the highest correlation with measured TI was 2 0.52 r = . Much better results are obtained with a triplet defined by choosing two different amino acid scales and one smoothing technique. In this way we have assigned 2700 scalar descriptors to each triplet. The best correlation between descriptor and observed TI in the training data set is assigned to the chosen triplet. Out of thousands of triplets, only 3 corresponded to correlation coefficients 2 0.81 r ≥ in the training data set. The sequence moments for these best descriptors were obtained by summing all sequence environment vectors i.e. by using the smoothing process which excludes the central amino acid in the sliding window (Figure 1) .
The simplest descriptor (among 3 best descriptors corresponding to these triplets) was the cosine of the angle between sequence moments associated with Janin's 11 and Guy's 12 hydrophobicity scale, a peptide sequence bending arc of α = π/2 and pondering factor q = 1/3. It was named the D descriptor. It is associated with a correlation 2 r = 0.829 when the training data set is used (Supplementary Figure S1) . The remaining two descriptors were significantly more complex and only one of them was associated with a slightly higher correlation coefficient Figure S2) .
We have somewhat misused statistical methods here. Namely, the data in both the training set and in the testing set are not normally distributed. Hence, standard statistical practice would be not to use Pearson r correlation, but to use a non-parametric methods instead. However, we are not interested in an index that correctly orders peptides according to their TI, but to find an index that well predicts which peptides have a very high value of TI. It can be easily shown that a given percent error in predicting peptides with high values of TI much more influences the Pearson correlation coefficient then the same percent error in predicting peptides with the low values of TI. Therefore, r extracts information which is significant to our study.
We addressed also the concern that a small number of peptides with high measured TI in the training data set (11 peptides with 20 TI ≥ ) are examined by selecting one among millions of descriptors. In order to verify that our predictions are not purely casual, we performed the same computation, but for each of the amino acid scales we have randomly permuted the data. In three such experiments the best values of 
The AMP-Designer algorithm and associated restrictions
The basic idea of the algorithm is to support the design of highly selective frog-type helical peptide antibiotics by combining D descriptor based TI prediction with rational physicochemical and statistical restrictions based on the structural characteristics of such AMPs. A first set of applied restrictions are very simple general requirements, such as: 1) D descriptor predicted TI > than 85 (the maximum predicted TI is 96 in the D descriptor model); 2) peptide net positive charge = 4 or 5 (as most frequent in natural helical AMPs 3 ); 3) mean hydrophobicity (using the CCS scale, see below 14 ) = -0.5 to -1.5 (as most often found for helical AMPs 3 ). 4) non-polar residues A, L, M, V, I, F, W are copmletely separate from polar residues E, D, Q, N, G, K, R in a helical wheel projection (limiting design to helix-forming amphipathic peptides that have glycine residues in the polar helix face); 5) no more than 2 identical neighboring amino acids (to avoid trivial cases with long segments of identical amino acids that do not occur in natural AMPs); 6) the three C-terminal amino acids should be the C-terminal residues in at least one good natural peptide antibiotic.
The remaining restrictions have been obtained by statistical analyses of the set of best peptides (SBP) ( 20 TI ≥ , the first 11 and the first 15 peptides respectively from the AMPad database training and testing data sets), and by statistical analyses of the full set of peptides (SAP) (all AMPad peptides, Supplementary tables S1 and S2). These restrictions are: 7) the first amino acid (AA) should be G, because most peptides in SBP start by G; 8) the second AA should be either L or I , since most of peptides starting with G in SBP have L or I on the second position; 9) residues with the highest amino acid selectivity index associated with SBP peptides are E , Q , H , G and D (Supplementary Table S3) , hence at least 9 such AAs should be present in a peptide; 10) the successor of each AA should be one of the five most common successors of that AA in the SBP data set (Supplementary Table S4) ; 11) the AA placed at the 4 i + position with respect to any AA (spatially close in an α -helical conformation) should be one of the five most common successors at distance 4 i + of that AA in the SBP data set (Supplementary Table S5) 12) the motif regularity index should be less then 2. This index determines how well the designed peptide p incorporates motifs that are the most common in the structure of antimicrobial peptides in the SBP data set (see Supplementary Method S2 and  Supplementary Tables S4 and S5 ).
Based on these restrictions, we selected the following peptides out of 8x10 29 possible ones:
GLKGLLGKALKGIGKHIGKAQGC; GLKGLLGKALGEAKGLLGKHKGC; GITQGVLKGIGKHVGKALKGIGC; GIGKHVGKALKGLKGLLKGLGEC; GIGKHVGKALKGVKGLLKGLGEC; GIGKHVGKALGELKGLLKGLKGC; GIGKHVGKALKGLKGLLKGLGES;
The last peptide, DESC 1, was selected for synthesis and characterization. It is unlike any known helical peptide. A suitable name for this novel peptide would be adepantin 1, an abbreviation for Automatically Designed Peptide Antibiotic No. 1.
Mean hydrophobicity and relative amphipathicity
The global hydrophobicity and the amphipathicity for each synthesized peptide sequence were calculated using a hydrophobicity index (Hi) scale derived from the normalized and filtered consensus of 163 published scales, that is arbitrarily ranged between maximum values of +10 for Phe, and -10 for Arg 3, 14 . The hydrophobicity is given as the mean value (H = (∑Hi)/ l ), where l = peptide length. The mean hydrophobic moment (µHmax) was calculated as described by Eisenberg et al. 7 . The relative amphipathicity (µH/µHmax) for each peptides was then determined with respect to the value of the maximum hydrophobic moment for a perfectly amphipathic, 18-residue peptide composed only of Phe and Arg (µHmax = 6.4 with our scale). This relative measure of amphipathicity is less likely to vary according to the scale used, than an absolute value.
Peptide synthesis, purification and characterization DESC 1 amide, ascaphin-1 amide (ASC 1) and pseudin-2 amide (PSEU 2) were synthesized by Fmoc-solid phase peptide synthesis on a Microwave-enhanced CEM Liberty synthesizer using Fmoc-PAL-PEG-PS resin (substitution 0.34 mmol/g). The cleaved/deprotection cocktail was trifluoroacetic acid, water and triisopropylsilane (95:2.5:2.5). The crude peptides were purified on a preparative Waters XTerra® C18, 7 µm, 300 Å, 19x300 mm column using a 25-45% CH 3 CN in 60 min gradient with a 5 ml/min flow. Peptides quality and purity were verified by mass spectrometry (Esquire 4000 Ion Trap, Bruker Daltonics Inc, Germany), while peptide concentrations were determined by mass and verified by the Waddell method 20 . The capacity of each synthesized peptide to assume a helical conformation was probed by CD spectroscopy on a Jasco J-715 spectropolarimeter (Jasco, Japan), using 2 mm path length quartz cells and peptide concentrations of 20 µM, in 5 mM sodium phosphate buffer pH7, in the absence and presence of 50 % (v/v) TFE. All spectra are the mean of at least two trials, each with the accumulation of three scans. Helical content (% Helix) was estimated from the molar ellipticity at 222 nm, according to the method of Chen 21 .
Hemolytic activity (HC 50 )
The hemolytic activity of peptides was assessed using freshly isolated human erythrocytes from healthy donors, by monitoring the release of hemoglobin at 405 nm. Aliquots of cell suspension (0.5% erythrocytes) were incubated in triplicate with different peptide concentrations (from 10 µM to 800 µM) in PBS at 37 o C for 30 minutes. Total lysis (100% hemolysis) was determined by addition of 0.2% Triton X-100. The HC 50 value was taken as the mean concentration of the peptide producing 50% hemolysis.
Antimicrobial activity and therapeutic index determination
The bacteriostatic activity of the peptides was determined against Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853 and Staphylococcus aureus ATCC (10 5 cfu/ml bacteria), as minimum inhibitory concentrations (MIC), using the microdilution susceptibility test in MH broth as described previously 13 , or as the effect on bacterial growth kinetics (10 6 cfu/ml bacteria in PBS) in the presence of different peptide concentrations (2, 4 and 8 µM), monitoring the optical density at 600 nm for 4h. The therapeutic index (TI) is defined as the ratio of HC50/MIC. Tables S3, S4 and S5, A.T. directing experiments, Figure 2 , Table 1, Supplementary Figures S3 and S4, Supplementary Table S6 , writing part of manuscript and methods dealing with experiments, N.A., peptide synthesis, purification and characterization; hemolytic and antimicrobial activities, extracting primary data; N.I. experiments on antibacterial activity, homology analysis, Figure 1 and Supplementary Figure  S5 .
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The authors declare that they have no competing financial interests. where q is a constant in the range 0 to 1, models the observation that amino acids closer to the N-terminus are more relevant for peptide's activity 3, 13 . After performing vector summation of ( ) ( ) ( ) ( ) ( ) Table 1 . Biological activities and therapeutic index determination 1 DESC1 = GIGKHVGKALKGLKGLLKGLGES-NH 2 , ASC 1 = ascaphin 1 22 , PSEU 2 = pseudin 2 23 . 2 Carried out in 100 % (v/v) MH broth with 10 5 CFU/ml bacteria in the logarithmic phasemean of at least three experiments performed in duplicate. 3 Calculated from % lysis vs concentration plots, see Fig. 2 -the mean of two experiments performed in triplicate. 4 TI, therapeutic index 5 Calculated for the indicated concentration of peptide, at the 4 th hour, from bacterial growth kinetics curves, monitoring OD at 600nm (100% v/v MH broth, 10 6 CFU/ml logarithmic phase bacteria) -mean of two experiments performed in triplicate).
